Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
A

CLL/SLL: Outcomes of Pts With Richter's Transformation Without Prior Chemoimmunotherapy

By Insights from 2023 ASH Annual Meeting FEATURING Adam Kittai
By Insights from 2023 ASH Annual Meeting FEATURING Adam Kittai
357 views
December 22, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

04:26
Pharmacosmos Hematology

An Introduction to an IV iron replacement therapy

Feat. H. Bahrain

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Lymphoma
06:43

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

V. Yazbeck

172 views
11:40

ASH 2023 Insights: "The European MCL Network R2 Elderly Trial - R2 v…

Insights from 2023 ASH Annual Meeting

V. Ribrag

41 views
08:29

ASH 2023 Insights: "CAR T-Cell Therapy in Aggressive Lymphomas - Ide…

Insights from 2023 ASH Annual Meeting

A. Sureda

74 views
05:12

ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronextamab…

Insights from 2023 ASH Annual Meeting

J. C. Villasboas

59 views
08:30

ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic Hodg…

Insights from 2023 ASH Annual Meeting

S. Desai

92 views
11:11

ASH 2023 Insights: "Ibrutinib and Venetoclax in Symptomatic, Treatme…

Insights from 2023 ASH Annual Meeting

J. Castillo

118 views
09:27

ASH 2023 Insights: "Ph2 EpiRCHOP Study - Tazemetostat With R-CHOP in…

Insights from 2023 ASH Annual Meeting

C. Sarkozy

106 views
09:10

ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & Rituximab …

Insights from 2023 ASH Annual Meeting

P. Strati

71 views
06:00

ASH 2023 Insights: "Effectiveness of CIT and Novel Therapies in 2L+ …

Insights from 2023 ASH Annual Meeting

L. Nastoupil

107 views
09:05

ASH 2023 Insights: "Time-Limited Exposure to a ROR1-Targeting Bispec…

Insights from 2023 ASH Annual Meeting

P. Jasani

37 views
06:09

CLL/SLL: Outcomes of Pts With Richter's Transformation Without Prior…

Insights from 2023 ASH Annual Meeting

A. Kittai

357 views
05:45

ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter's Trans…

Insights from 2023 ASH Annual Meeting

A. Kittai

49 views
13:38

ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuximab V…

Insights from 2023 ASH Annual Meeting

S. Castellino

34 views
02:27

ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Patient…

Insights from 2023 ASH Annual Meeting

C. Cheah

68 views
02:26

ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax in Pa…

Insights from 2023 ASH Annual Meeting

C. Cheah

48 views
10:19

ASH 2023 Insights: "Final Analysis of the ELM-2 Study - Odronextamab…

Insights from 2023 ASH Annual Meeting

S. Ayyappan

129 views
10:57

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With …

Insights from 2023 ASH Annual Meeting

E. Budde

132 views
13:46

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitamab, Ri…

Insights from 2023 ASH Annual Meeting

J. Westin

186 views
30:24

ASH 2023 Insights: "Treatment of Older Patients With HL in the Moder…

Insights from 2023 ASH Annual Meeting

A. Evens

153 views
10:58

ASH 2023 Insights: "ViPOR Trial - Multi-Targeted Therapy With Veneto…

Insights from 2023 ASH Annual Meeting

C. Melani

60 views
11:05

ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib …

Insights from 2023 ASH Annual Meeting

C. Andreadis

41 views
06:30

ASH 2023 Insights: "Pirtobrutinib in R/R FL - Results From the Ph1/2…

Insights from 2023 ASH Annual Meeting

N. Shah

68 views
11:11

ASH 2023 Insights: "Prognostic Utility of MRD After Curative Intent …

Insights from 2023 ASH Annual Meeting

B. Sworder

133 views
08:59

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in Older …

Insights from 2023 ASH Annual Meeting

S. Rutherford

206 views
11:43

ASH 2023 Insights: "Selection of Bispecific Antibody Therapies or CA…

Insights from 2023 ASH Annual Meeting

M. Kamdar

177 views
16:09

ASH 2023 Insights: "Addition of Inotuzumab Ozogamicin to the Conditi…

Insights from 2023 ASH Annual Meeting

I. Khouri

27 views
10:21

ASH 2023 Insights: "EOT Response Assessment After 1L Tx For Aggressi…

Insights from 2023 ASH Annual Meeting

M. Roschewski

82 views
13:06

ASH 2023 Insights: "ECOG-ACRIN E4412 Study of Ipi, Nivo, and Brentux…

Insights from 2023 ASH Annual Meeting

C. Diefenbach

24 views
18:05

ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentuximab…

Insights from 2023 ASH Annual Meeting

N. Grover

25 views
09:56

ASH 2023 Insights: "Limited Duration Loncastuximab Tesirine With Rit…

Insights from 2023 ASH Annual Meeting

J. Pablo Alderuccio

54 views
11:42

ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcomes in …

Insights from 2023 ASH Annual Meeting

N. Epperla

84 views
04:34

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Insights from 2023 ASH Annual Meeting

P. Jain

196 views
05:10

ASH 2023 Insights: "Efficacy of Double Step-Up Dosing of AZD0486, a …

Insights from 2023 ASH Annual Meeting

S. Gaballa

93 views
05:41

ASH 2023 Insights: "Acalabrutinib With Rituximab as 1L Therapy for O…

Insights from 2023 ASH Annual Meeting

P. Jain

48 views
04:56

ASH 2023 Insights: "Immune Reconstitution and Infection Patterns Fol…

Insights from 2023 ASH Annual Meeting

M. Melody

115 views
10:28

ASH 2023 Insights: "Multicenter Study of MCL Outcomes Following 1L B…

Insights from 2023 ASH Annual Meeting

Y. Wang

60 views